Clinical Trials Logo

Clinical Trial Summary

Postoperative atrial fibrillation (POAF) is a common complication following cardiac surgery and leads to worse outcomes. POAF is thought to be caused by the inflammatory state following cardiac surgery. It may be that anti-inflammatory medications could lower the occurrence of POAF, however many typical anti-inflammatory medications, such as ibuprofen, are contraindicated in the post cardiac surgery patient due to increased risks of bleeding. If a drug was identified with anti-inflammatory properties with minimal deleterious side effects, this could be broadly applied to cardiac surgery patients for the prevention of POAF. Interestingly, several small trials have shown that medications that alter transcription of inflammatory markers lead to decreased POAF. Furthermore, we have shown that phytochemicals, such as those found in grapes, have excellent bioavailability and can affect cardiac gene transcription related to inflammation. In this study, we propose to evaluate the efficacy of preoperative administration of concentrated grape powder in the prevention of POAF.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05991700
Study type Interventional
Source University of Michigan
Contact China Green, BS
Phone 734-936-7731
Email chjgreen@med.umich.edu
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date July 2024
Completion date June 2025

See also
  Status Clinical Trial Phase
Recruiting NCT03793465 - Pilot-Tart Cherry, Mitral Transcriptome, and POAF Incidence Phase 1/Phase 2